1. Home
  2. IBRX vs ZWS Comparison

IBRX vs ZWS Comparison

Compare IBRX & ZWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

N/A

Current Price

$6.09

Market Cap

8.2B

Sector

Health Care

ML Signal

N/A

Logo Zurn Elkay Water Solutions Corporation

ZWS

Zurn Elkay Water Solutions Corporation

N/A

Current Price

$44.13

Market Cap

8.4B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
IBRX
ZWS
Founded
2014
1900
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
8.4B
IPO Year
2015
2008

Fundamental Metrics

Financial Performance
Metric
IBRX
ZWS
Price
$6.09
$44.13
Analyst Decision
Strong Buy
Buy
Analyst Count
4
10
Target Price
$14.25
★ $52.89
AVG Volume (30 Days)
★ 12.0M
1.3M
Earning Date
11-09-2026
10-27-2026
Dividend Yield
N/A
★ 1.17%
EPS Growth
★ 38.71
25.00
EPS
N/A
★ 1.47
Revenue
$113,288,000.00
★ $1,530,500,000.00
Revenue This Year
$99.98
$9.39
Revenue Next Year
$108.29
$4.48
P/E Ratio
★ N/A
$30.34
Revenue Growth
★ 668.31
19.40
52 Week Low
$1.95
$42.89
52 Week High
$12.43
$55.00

Technical Indicators

Market Signals
Indicator
IBRX
ZWS
Relative Strength Index (RSI) 36.40 39.56
Support Level N/A $43.18
Resistance Level $8.62 $46.23
Average True Range (ATR) 0.57 1.16
MACD -0.10 -0.01
Stochastic Oscillator 10.19 27.55

Price Performance

Historical Comparison
IBRX
ZWS

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

About ZWS Zurn Elkay Water Solutions Corporation

Zurn Elkay Water Solutions Corp is a growth-oriented, pure-play water management business that designs, procures, manufactures, and markets the broadest sustainable product portfolio of specification-driven water management solutions to improve health, hydration, human safety and the environment. Its product portfolio includes professional grade water safety and control products, flow systems products, hygienic and environmental products, and filtered drinking water products for public and private spaces that deliver superior value to building owners, positively impact the environment and human hygiene and reduce product installation time.

Share on Social Networks: